Fate Therapeutics (FATE)
NASDAQ:FATE
Want to see FATE full AI Analyst Report?
Fate Therapeutics (FATE) Ownership Overview
13.15% Insiders
12.52% Mutual Funds
18.45% Other Institutional Investors
8.70% ETFs
47.18% Public Companies and
Individual Investors
The ownership structure of Fate Therapeutics (FATE) stock is a mix of institutional, retail, and individual investors. Approximately 39.66% of the company’s stock is owned by Institutional Investors, 13.15% is owned by Insiders, and 47.18% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 12, 2026 | xxxxxxxxxxxxx | $5553 | |
Jan 12, 2026 | xxxxxxxxxxxxx | $11224 | |
Aug 05, 2025 | xxxxxxxxxxxxx | $9489 | |
Aug 05, 2025 | xxxxxxxxxxxxx | $15334 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $947026 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $77719 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $286380 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,884,277 | Insider | 11.05% | 22,611,906 | |
| 4,999,419 | Institution | 4.29% | 8,773,980 | |
| 4,043,758 | Institution | 3.47% | 7,096,795 | |
| 3,740,068 | Institution | 3.21% | 6,563,819 | |
| 2,904,835 | Institution | 2.49% | 5,097,985 | |
| 2,485,018 | Institution | 2.13% | 4,361,207 | |
| 1,184,952 | Institution | 1.02% | 2,079,591 | |
| 1,024,499 | Institution | 0.88% | 1,797,996 | |
| 869,487 | Institution | 0.75% | 1,525,950 | |
| 789,188 | Institution | 0.68% | 1,385,025 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,043,758 | Institution | 3.47% | 7,096,795 | |
| 2,904,835 | Institution | 2.49% | 5,097,985 | |
| 1,184,952 | Institution | 1.02% | 2,079,591 | |
| 1,024,499 | Institution | 0.88% | 1,797,996 | |
| 869,487 | Institution | 0.75% | 1,525,950 | |
| 729,188 | Institution | 0.63% | 1,279,725 | |
| 623,027 | Institution | 0.53% | 1,093,412 | |
| 560,497 | Institution | 0.48% | 983,672 | |
| 510,751 | Institution | 0.44% | 896,368 | |
| 367,000 | Institution | 0.31% | 644,085 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,974,111 | Institution | 2.55% | 3,568,933 | |
| 2,534,738 | Institution | 2.17% | 5,703,161 | |
| 1,103,967 | Institution | 0.95% | 1,324,760 | |
| 907,033 | Institution | 0.78% | 2,040,824 | |
| 537,110 | Institution | 0.46% | 644,532 | |
| 515,362 | Institution | 0.44% | 1,123,489 | |
| 298,626 | Institution | 0.26% | 671,909 | |
| 293,954 | Institution | 0.25% | 352,745 | |
| 277,504 | Institution | 0.24% | 624,384 | |
| 85,901 | Institution | 0.07% | 127,133 |
FAQ
Who Owns Fate Therapeutics (FATE)?
According to the latest TipRanks data, approximately 18.45% of the company's stock is held by institutional investors, 13.15% is held by insiders, and 47.18% is held by retail investors.
What percentage of Fate Therapeutics (FATE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 18.45% of Fate Therapeutics (FATE) stock is held by institutional investors.
What percentage of Fate Therapeutics (FATE) stock is held by retail investors?
According to the latest TipRanks data, approximately 47.18% of Fate Therapeutics (FATE) stock is held by retail investors.
Who owns the most shares of Fate Therapeutics (FATE)?
Redmile Group, Llc owns the most shares of Fate Therapeutics (FATE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.